ESP Block in MIS Lumbar Spine Surgery

Description

This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.

Conditions

Patients With Spinal Stenosis Indicated for MIS TLIF

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.

Erector Spinae Plane Block in Patients Undergoing Minimally Invasive Lumbar Spine Surgery: A Randomized Controlled Trial

ESP Block in MIS Lumbar Spine Surgery

Condition
Patients With Spinal Stenosis Indicated for MIS TLIF
Intervention / Treatment

-

Contacts and Locations

New York

Hospital for Special Surgery, New York, New York, United States, 10021

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18-80
  • * Patients scheduled for MIS TLIF (any level) with the principal investigator
  • * ASA 1, 2, 3
  • * ASA 4 or higher
  • * BMI \>40
  • * Chronic opioid use (daily use for \> 3 months)
  • * Revision surgery, any history of previous lumbar spine surgery
  • * Allergy to any of the study medications
  • * Non-English speaking
  • * Chronic renal insufficiency or failure (creatinine \>2) or severe hepatic disease (cirrhosis, failure)
  • * Pregnancy
  • * Any concomitant surgery

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Hospital for Special Surgery, New York,

Study Record Dates

2026-07-15